Learning from osteoporosis: TCF4 as a promising companion biomarker for breast cancer

Int J Rheum Dis. 2023 Jul;26(7):1220-1221. doi: 10.1111/1756-185X.14674.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers
  • Breast Neoplasms* / genetics
  • Female
  • Humans
  • Osteoporosis* / diagnostic imaging
  • Osteoporosis* / drug therapy
  • Transcription Factor 4

Substances

  • Biomarkers
  • TCF4 protein, human
  • Transcription Factor 4